22.10.2023, 2818 Zeichen

Marinomed: Marinomed Biotech AG has taken steps to further increase the flexibility of its corporate financing. Marinomed has agreed on an adjustment of the Convertible Notes Funding Program running since October 2021 (initial maturity September 2023) and its extension until October 2024 with the Swiss investment company Nice & Green S.A. So far, 50% of the original program volume of €5.4 million in convertible bonds have been issued and converted into ordinary shares of Marinomed. In the meantime, the program was paused from July to December 2022 and since March 2023. In order to take the share price, the share liquidity as well as the dilution effect on existing shareholders into account and to secure the ongoing project financing as well, it was agreed to continue the program, but to reduce the tranches from € 300k to € 160k. Also in the future, Marinomed will have the option to suspend the issuance of individual tranches of convertible bonds to react to the actual cash needs of the Company and the situation on the capital markets.
Marinomed Biotech: weekly performance: -6.98%

Bawag: Banking group Bawag published the financial results for the third quarter 2023, reporting a net profit of € 186 million, earnings per share € 2.25, and an RoTCE of 27.6%. The operating performance of our business was strong with pre-provision profits of € 268 million and a cost-income ratio of 31.3%. For the first nine months, Bawag Group reported a net profit of € 506 million, earnings per share of € 6.13, an RoTCE of 24.9%, and a CIR of 31.8%. Anas Abuzaakouk, CEO, commented: “We delivered another record quarterly result with net profit of € 186 million and an RoTCE of 28% for the third quarter. With our strong operating performance, we are on track to deliver a record year of earnings and expect to meet or exceed all 2023 targets despite an overall subdued market and cautious consumer sentiment. We target to complete our recently approved €175 million share buyback program by the end of the year and will address any further capital distributions with year-end results based on current M&A prospects, market developments, and subject to regulatory approvals.'
Bawag: weekly performance: -7.86%

Kapsch TrafficCom: Kapsch TrafficCom announces that it has won the tender to provide direct customer service for the Polish e-TOLL. The contract is worth PLN 62.87 million (as of October 16, 2023: around EUR 14 million) and will run for three years from February 1, 2024. Under the contract, Kapsch will provide customer service for the e-TOLL system at 100 distribution points across Poland. The distribution points will be open all year round and around the clock for motorists.
Kapsch TrafficCom: weekly performance: -3.33%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (17/10/2023)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #790: ATX schwächer, FMA kommuniziert Rekordstrafe, EVN heute 35 Jahre an der Börse, Socgen Day in Wien

Bildnachweis

Aktien auf dem Radar:Pierer Mobility, voestalpine, Warimpex, Immofinanz, CA Immo, Addiko Bank, Andritz, Frequentis, AT&S, Zumtobel, OMV, FACC, Uniqa, Strabag, Austriacard Holdings AG, Amag, Cleen Energy, DO&CO, Marinomed Biotech, UBM, Wolford, Oberbank AG Stamm, Kapsch TrafficCom, Agrana, Erste Group, EVN, Flughafen Wien, Palfinger, Österreichische Post, S Immo, Telekom Austria.

---